Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 25

Results For "GTHE"

2252 News Found

FICCI and Lilly launch Bharat Life Sciences Awards to recognise India’s scientific excellence
R&D | June 03, 2026

FICCI and Lilly launch Bharat Life Sciences Awards to recognise India’s scientific excellence

A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India


Cancer drug “iza-bren” posts strong Phase 3 wins across multiple tumor types
Clinical Trials | June 03, 2026

Cancer drug “iza-bren” posts strong Phase 3 wins across multiple tumor types

The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials


CORONA Remedies receives EU-GMP certification for hormone facility
News | June 02, 2026

CORONA Remedies receives EU-GMP certification for hormone facility

Accreditations for Bhayla manufacturing site strengthen the company’s global quality credentials and support expansion of its hormone portfolio into regulated international markets


Yoginii partners with Panacea Biotec to expand wellness portfolio
Healthcare | June 02, 2026

Yoginii partners with Panacea Biotec to expand wellness portfolio

Collaboration brings Staart Prime, ChilRun and NikoMom products to Yoginii’s platform, strengthening its family-focused wellness ecosystem and supporting women through motherhood and family care


Imaging Endpoints appoints Srikanth Ayyappan as AVP, Global Marketing
People | June 02, 2026

Imaging Endpoints appoints Srikanth Ayyappan as AVP, Global Marketing

Based in the global marketing function, he will be responsible for strengthening the company's visibility among sponsors, partners and industry stakeholders worldwide


Moderna and Merck’s mRNA cancer vax combo shows 5-year survival in melanoma trial
Clinical Trials | June 02, 2026

Moderna and Merck’s mRNA cancer vax combo shows 5-year survival in melanoma trial

An exploratory overall survival signal also leaned in favor of the combination, though the companies noted the result remains preliminary


Ebola vax on the anvil?
News | June 02, 2026

Ebola vax on the anvil?

CEPI will commit up to US $50 million to fund preclinical research and Phase 1 clinical trials of Moderna’s mRNA-based vaccine candidate


Bristol Myers Squibb wins EU approval for Opdivo-based frontline treatment in advanced hodgkin lymphoma
Drug Approval | June 02, 2026

Bristol Myers Squibb wins EU approval for Opdivo-based frontline treatment in advanced hodgkin lymphoma

The approval is supported by results from the Phase 3 SWOG 1826 trial


AIIMS Delhi and Raipur use Intuitive’s tech to conduct tele-mentored robotic surgery
Hospitals | June 02, 2026

AIIMS Delhi and Raipur use Intuitive’s tech to conduct tele-mentored robotic surgery

Real-time remote collaboration during robotic-assisted cholecystectomy showcases new possibilities for surgical mentoring, education, and knowledge sharing across institutions